23.01.2019 10:45
Dicronis, the developer of Lymphit a diagnostic tool for early tracking of lymphedema, is joining the Merck Accelerator program in Darmstadt. Over three months, the startup will receive monitoring, coaching and up to €50,000. For the first time, all participants have the chance to join the Merck China Innovation Hub in Shanghai for an extension of the program.